Hydroxychloroquine-Induced Pigmentation in Patients With Systemic Lupus Erythematosus
Author(s) -
M. Jallouli,
Camille Françès,
JeanCharles Piette,
D. Lê Thi Huong,
Philippe Moguelet,
Cécile Factor,
Noël Zahr,
Makoto Miyara,
David Saadoun,
Alexis Mathian,
Julien Haroche,
C. De Gennes,
Gaëlle Leroux,
C. Chapelon,
B. Wechsler,
P. Cacoub,
Zahir Amoura,
N. CostedoatChalumeau
Publication year - 2013
Publication title -
jama dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.128
H-Index - 166
eISSN - 2168-6084
pISSN - 2168-6068
DOI - 10.1001/jamadermatol.2013.709
Subject(s) - hydroxychloroquine , medicine , dermatology , lupus erythematosus , hyperpigmentation , skin biopsy , ecchymosis , biopsy , surgery , immunology , disease , antibody , covid-19 , infectious disease (medical specialty)
Hydroxychloroquine-induced pigmentation is not a rare adverse effect. Our data support the hypothesis that hydroxychloroquine-induced pigmentation is secondary to ecchymosis or bruising.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom